Sarcoidosis: Drugs under Investigation
- PMID: 28750466
- DOI: 10.1055/s-0037-1603768
Sarcoidosis: Drugs under Investigation
Conflict of interest statement
Disclosure The authors report no conflicts of interest in this work.
Similar articles
-
Current Medical Therapy for Sarcoidosis.Semin Respir Crit Care Med. 2017 Aug;38(4):523-531. doi: 10.1055/s-0037-1604032. Epub 2017 Jul 27. Semin Respir Crit Care Med. 2017. PMID: 28750465 Review. No abstract available.
-
TNF--a antagonists and sarcoidosis.QJM. 2011 Apr;104(4):374. doi: 10.1093/qjmed/hcr009. Epub 2011 Jan 28. QJM. 2011. PMID: 21278060 No abstract available.
-
[TNFα blocking agents and sarcoidosis: an update].Rev Med Interne. 2010 Dec;31(12):828-37. doi: 10.1016/j.revmed.2010.02.007. Epub 2010 May 26. Rev Med Interne. 2010. PMID: 20510487 French.
-
Treatment of sarcoidosis.Semin Respir Crit Care Med. 2010 Aug;31(4):501-18. doi: 10.1055/s-0030-1262218. Epub 2010 Jul 27. Semin Respir Crit Care Med. 2010. PMID: 20665400 Review.
-
Systemic treatment of sarcoidosis.Ocul Immunol Inflamm. 2011 Apr;19(2):145-50. doi: 10.3109/09273948.2010.542870. Ocul Immunol Inflamm. 2011. PMID: 21428758
Cited by
-
Safety and efficacy of abatacept in patients with treatment-resistant SARCoidosis (ABASARC) - protocol for a multi-center, single-arm phase IIa trial.Contemp Clin Trials Commun. 2020 May 29;19:100575. doi: 10.1016/j.conctc.2020.100575. eCollection 2020 Sep. Contemp Clin Trials Commun. 2020. PMID: 32551397 Free PMC article.
-
Genetic and geographic influence on phenotypic variation in European sarcoidosis patients.Front Med (Lausanne). 2023 Aug 9;10:1218106. doi: 10.3389/fmed.2023.1218106. eCollection 2023. Front Med (Lausanne). 2023. PMID: 37621457 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical